ABOUT ECPO ⌄
- - About ECPO
    Working collaboratively across Europe to improve the lives of people who are living with and are affected by the chronic disease of obesity through advocacy, policy and education.
ADVOCACY ⌄
- - ECPO Advocates
    EASO ECPO serves to elevate and promote the needs and interests of the European patient community with a broad range of stakeholders, including EASO scientific and clinical communities, media and industry.
EDUCATION ⌄
- - Education
    Obesity is a complex chronic relapsing disease that increases a persons risk of other diseases and comorbidities.
PEOPLE FIRST ⌄
- - People First
    People First language has been widely adopted for most chronic diseases and disabilities – but not obesity. We believe it’s time to make a change.
ECPO MEDIA ⌄
- - Patient Resources
    Bringing all of ECPO resources into one easy to reach and easy to navigate space.

Home
Home
Article

IFPMA Note for Guidance on Patient and Patient Organization Interactions

April 3, 2020
Andrew
News
Advice obesity

Pharma industry and patient groups collaborate on a NEW guidance note on best practices for interaction

The International Association of Pharmaceutical Manufacturers and Associations (IFPMA) and the International Association for Patients’ Associations (IAPO) announce the launch of an advisory Note for Guidance for IFPMA member companies and associations worldwide on best practice for interaction with patients, caregivers, and patient organizations. The guidance also advises on the design and implementation of patient support programs that are supported by IFPMA members.